Filtros de búsqueda

Lista de obras de

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

artículo científico publicado en 2004

Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial

artículo científico publicado en 2017

Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial

Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial

artículo científico publicado en 2013

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin

artículo científico publicado en 2015

CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm

artículo científico publicado en 2016

CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM

Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure　– Subanalysis of the WARCEF Trial –

Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial

artículo científico publicado en 2014

Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study

artículo científico publicado en 2006

Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial

Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies

artículo científico publicado en 2005

Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial

artículo científico publicado en 2016

Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy

artículo científico publicado en 2015

Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial

artículo científico publicado en 2014

Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure

artículo científico publicado en 2017

The first prognostic model for stroke and death in patients with systolic heart failure

artículo científico publicado en 2015

Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm ⬇️

artículo científico publicado el 2 de mayo de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda